← Back to Treatments
🏅 FDA Orphan Designation

Triostat

Liothyronine sodium injection

Manufacturer: SmithKline Beecham Pharmaceuticals

Indicated for:
Hypo- and hypermelanotic cutaneous macules-retarded growth-intellectual disability syndromeOrphanMyeloid sarcoma

FDA-Approved Indications (2)

Treatment of myxedema coma/precoma.

Treatment of myxedema coma/precoma

Population: all ages

Indications & Usage

Treatment of myxedema coma/precoma.

💙 Support Programs

View all →
Triostat
SmithKline Beecham Pharmaceuticals

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.